ctrl K

Watchlist Price Alert

Pyxis Oncology Inc. (PYXS)

NASDAQ: PYXS · Real-Time Price · USD

1.14

0.03 (2.70%)

At close: May 16, 2025, 11:36 AM

Pyxis Oncology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	16.15M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	475K	2M	1.84M	1.25M	444K	n/a
Gross Profit	15.67M	-2M	-1.84M	-1.25M	-444K	n/a
Operating Income	-89.46M	-82.2M	-123.48M	-69.72M	-12.89M	-2.88M
Interest Income	7.04M	6.63M	2.76M	23K	66K	107K
Pretax Income	-79.5M	-73.79M	-120.72M	-75.97M	-12.83M	-2.77M
Net Income	-77.33M	-73.79M	-117.95M	-81.54M	-12.76M	-2.67M
Selling & General & Admin	25.42M	32.61M	37.35M	18.66M	3.85M	1.66M
Research & Development	58.75M	47.89M	86.13M	51.05M	9.05M	1.22M
Other Expenses	20.96M	n/a	n/a	181K	n/a	n/a
Operating Expenses	105.13M	82.2M	123.48M	69.72M	12.89M	2.88M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	105.61M	82.2M	123.48M	69.72M	12.89M	2.88M
Income Tax Expense	-2.16M	n/a	-2.76M	5.56M	-66K	-107K
Shares Outstanding (Basic)	58.45M	39.9M	33.03M	32.22M	34.31M	34.31M
Shares Outstanding (Diluted)	58.45M	39.9M	33.03M	32.22M	34.31M	34.31M
EPS (Basic)	-1.32	-1.85	-3.57	-2.53	-0.37	-0.08
EPS (Diluted)	-1.32	-1.85	-3.57	-2.53	-0.37	-0.08
EBITDA	-65.51M	-78.49M	-122.77M	-69.07M	-12.43M	n/a
EBIT	-68.5M	-80.42M	-123.48M	-69.72M	-12.89M	-2.77M
Depreciation & Amortization	2.98M	2M	1.84M	1.25M	444K	2.88M